Cryo-Cell International Inc. CCEL

4.24 0.21 5.21% as of 25 Sep
Market cap
$32.5M
P/E
0.0×
Nov '16 Nov '17 Nov '18 Nov '19 Nov '20 Nov '21 Nov '22 Nov '23 Nov '24 Nov '25
P/E ratio
0.00 24.42 0.00 26.32 15.96 47.62 12.85 0.00 170.80 0.00
P/S ratio
1.49 2.24 1.87 1.85 1.82 3.49 1.22 1.42 2.17 1.02
P/FCF ratio
7.42 10.13 11.66 10.83 7.06 103.33 0.00 34.84 32.44 8.24
P/Operating CF
13.45 26.96 64.73 52.34 19.01 60.41 15.23 13.34 32.19 25.07
P/B ratio
0.00 0.00 0.00 0.00 0.00 24.07 0.00 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
1.65 2.19 1.97 1.80 1.68 3.30 1.52 1.70 2.43 1.24
EV/EBITDA
13.84 10.35 10.25 10.27 6.24 17.63 7.89 0.00 17.19 20.99
EV/Operating CF
7.65 9.71 10.79 9.10 6.18 12.01 5.38 5.98 12.94 7.17
EV/FCF
8.22 9.88 12.28 10.54 6.53 97.67 (6.86) 41.61 36.33 10.08
Quick Ratio
0.62 0.85 0.83 0.88 1.02 0.65 0.40 0.36 0.50 0.51
Current Ratio
0.69 0.91 0.96 1.00 1.13 0.75 0.49 0.45 0.58 0.59
Net Debt/EBITDA
2.07 0.11 1.07 0.27 (0.50) (1.02) 1.56 (0.82) 1.84 3.83
Debt/Assets
50.26% 30.51% 30.53% 20.88% 13.46% 4.65% 16.73% 15.77% 18.29% 16.96%
Debt/Equity
(0.64) (0.58) (1.45) (1.29) (2.33) 0.67 (7.12) (0.87) (0.90) (0.56)
Asset Turnover
1.18 1.17 0.88 0.75 0.70 0.54 0.48 0.50 0.51 0.50
Operating CF/Net income
(3.78) 2.47 (6.24) 2.75 2.34 3.80 3.09 (0.94) 14.95 (2.26)
Capex/Depreciation
(0.15) (0.28) (1.51) (1.29) (0.62) (5.03) (8.38) (4.41) (3.46) (0.08)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
12.96% (16.59%) 7.98% (28.89%) (75.37%) 274.29% 208.38% 151.67% (3.32%) 15.27%
ROA
(6.77%) 10.66% (2.58%) 5.37% 8.14% 3.90% 4.41% (15.10%) 0.64% (3.84%)
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 33.07% 0.00% 0.00% 0.00%
Return on Tangible Assets
42.33% (722.11%) (103.79%) 126.94% 95.83% (101.10%) 74.26% (99.33%) 3.13% (18.69%)
Average Days of Receivables
63.96 73.70 73.29 69.95 74.10 66.38 72.72 76.58 83.41 79.16
Research and Development Expense of Revenue
0.23% 0.16% 0.31% 0.09% 0.08% 0.17% 1.27% 3.74% 3.88% 1.19%
Selling, General and Administrative Expense of Revenue
63.66% 53.11% 53.50% 46.80% 45.89% 50.58% 51.36% 54.77% 57.91% 57.72%
Intangible Assets out of Total Assets
0.01 0.01 0.08 0.07 0.08 0.30 0.26 0.05 0.04 0.05
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Graham Net Nets
(0.75) (0.42) (0.67) (0.59) (0.54) (0.40) (1.54) (1.41) (0.94) (2.14)
Graham Number
2.95 0.00 1.94 0.00 0.00 1.73 0.00 5.82 0.00 4.01
Earnings Yield
(4.79%) 4.09% (1.91%) 3.80% 6.27% 2.10% 7.78% (21.31%) 0.59% (7.79%)
Free Cash Flow Yield
13.47% 9.87% 8.58% 9.23% 14.17% 0.97% (18.18%) 2.87% 3.08% 12.13%
Revenue per Share
2.85 3.59 3.92 4.08 4.13 3.55 3.58 3.76 3.93 3.91
Operating CF per Share
0.61 0.81 0.71 0.81 1.12 0.97 1.01 1.07 0.74 0.68
Capex per Share
(0.04) (0.01) (0.09) (0.08) (0.06) (0.85) (1.81) (0.92) (0.44) (0.01)
Free Cash Flow per Share
0.57 0.80 0.63 0.72 1.06 0.12 (0.79) 0.15 0.30 0.66
Cash per Share
0.51 0.95 0.93 0.96 1.39 1.02 0.20 0.12 0.43 0.41
Shareholders Equity per Share
(1.90) (1.77) (1.19) (0.89) (0.35) 0.51 (0.18) (1.32) (1.63) (2.31)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(1.90) (1.77) (1.19) (0.89) (0.35) 0.51 (0.18) (1.32) (1.63) (2.31)
Free Cash Flow
4.65 5.62 4.69 5.63 8.02 0.97 (6.73) 1.28 2.41 5.36
Working Capital
(4.10) (1.20) (0.67) (0.04) 2.14 (5.29) (9.87) (11.41) (9.04) (8.03)
Capital Expenditures
(0.34) (0.10) (0.65) (0.66) (0.45) (6.95) (15.30) (7.64) (3.60) (0.12)
Net Current Asset Value
(25.94) (23.68) (36.54) (34.45) (30.31) (40.70) (56.80) (62.80) (65.34) (68.58)
EV/EBIT
88.04 11.09 11.09 11.31 6.83 23.70 11.46 0.00 22.35 81.46
Capex to Sales
0.01 0.00 0.02 0.02 0.01 0.24 0.50 0.24 0.11 0.00
Net Profit Margin
(5.71%) 9.12% (2.93%) 7.20% 11.64% 7.21% 9.14% (30.38%) 1.26% (7.70%)
Price to Operating Income
79.52 11.37 10.53 11.62 7.38 25.07 9.19 0.00 19.95 66.58
Other line items
Depreciation/Fixed assets
2.37 0.40 0.29 0.28 0.44 0.43 0.13 0.08 0.05 0.07
Cash ROIC
(272.61%) 320.08% 35.06% 47.08% 48.75% 30.60% (45.53%) 3,032.92% (752.73%) 321.41%
Accounts Receivable Turnover
6.50 5.53 5.32 5.32 5.02 4.99 5.37 4.97 4.61 4.46
Accounts Payable Turnover
4.10 3.94 5.35 7.63 8.30 7.35 5.68 3.51 3.14 3.10
Inventory Turnover
13.80 19.90 10.84 8.56 9.60 9.73 9.92 10.36 11.14 13.83
Average Days of Payables
93.89 104.68 53.93 49.79 36.18 60.49 66.64 138.10 86.44 142.05
Days of Inventory on Hand
22.82 17.08 53.88 39.44 35.05 37.40 35.34 33.45 30.20 20.23
Average Receivables
3.56 4.59 5.50 5.98 6.21 5.79 5.65 6.31 6.94 7.08
Average Payables
1.41 1.71 1.60 1.32 1.16 1.22 1.55 2.39 2.53 2.38
Average Inventory
0.42 0.34 0.79 1.17 1.01 0.92 0.89 0.81 0.71 0.53
Average Assets
19.52 21.72 33.15 42.64 44.54 53.43 62.78 63.05 62.95 63.20
Average Common Equity
(10.19) (13.96) (10.71) (7.93) (4.81) 0.76 1.33 (6.28) (12.12) (15.91)

Fold the line items

Columns are period end dates